Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

dolichol kinase Inhibitors

Dolichol kinase inhibitors constitute a category of compounds that can impede the enzymatic activity responsible for the phosphorylation of dolichol, a lipid essential for glycoprotein biosynthesis. These inhibitors encompass a range of chemicals that may not bind directly to dolichol kinase but can affect the enzyme's function through various indirect mechanisms. For instance, certain inhibitors operate by interfering with the upstream biosynthetic pathways of dolichol itself, thereby restricting the substrate availability for the kinase. Statin compounds like lovastatin and mevastatin exemplify this approach by inhibiting HMG-CoA reductase, a key enzyme in the mevalonate pathway, which is critical for the production of isoprenoids, the building blocks of dolichol. Consequently, such inhibition can result in a reduction of available dolichol for phosphorylation. Other compounds may exert their effects by disrupting the cellular structures or processes that facilitate the enzyme's function.

Furthermore, some inhibitors may influence the lipid metabolic processes or the expression of enzymes involved in the regulation of dolichol kinase. Fibrates like fenofibrate activate PPARα and can alter lipid metabolism, which in turn can affect the dolichol kinase activity due to changes in cellular lipid profiles. Inhibitors such as nicotinamide act on sirtuins, which are involved in the post-translational modification of proteins, including potentially those that regulate dolichol kinase activity. Other agents like zaragozic acid and terbinafine target specific enzymes in the cholesterol biosynthesis pathway, leading to a cascade of effects that could culminate in altered dolichol kinase activity. The influence of these compounds provides insight into the enzyme's modulation within the broader scope of cellular function. By altering the synthesis or availability of dolichol, the phosphorylation capacity of dolichol kinase can be modulated, impacting the glycosylation of proteins, a fundamental process for proper protein folding and cellular function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Inhibits the first step in the N-glycosylation pathway by blocking the transfer of N-acetylglucosamine to dolichol phosphate, potentially reducing the substrate availability for dolichol kinase.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$97.00
$328.00
$676.00
$1467.00
6
(1)

Known to inhibit DNA-dependent RNA polymerase and may indirectly affect dolichol kinase by altering the expression levels of proteins involved in its regulation.

Lovastatin

75330-75-5sc-200850
sc-200850A
sc-200850B
5 mg
25 mg
100 mg
$29.00
$90.00
$339.00
12
(1)

An HMG-CoA reductase inhibitor that can lower the synthesis of isoprenoids and subsequently affect the production of dolichol, possibly reducing the activity of dolichol kinase due to lower substrate levels.

Fenofibrate

49562-28-9sc-204751
5 g
$41.00
9
(1)

By activating peroxisome proliferator-activated receptor alpha (PPARα), it can influence lipid metabolism and indirectly affect dolichol kinase activity through changes in cellular lipid composition.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Disrupts the Golgi apparatus and could thereby influence the glycosylation processes in which dolichol kinase participates.

Terbinafine

91161-71-6sc-338609
100 mg
$560.00
1
(0)

Inhibits squalene epoxidase and could potentially reduce dolichol levels by affecting the upstream mevalonate pathway.

Mevastatin (Compactin)

73573-88-3sc-200853
sc-200853A
10 mg
50 mg
$77.00
$179.00
18
(1)

Similar to lovastatin, as another HMG-CoA reductase inhibitor, it can decrease the synthesis of isoprenoids and thus affect dolichol kinase by lowering its substrate availability.

Triacsin C Solution in DMSO

76896-80-5sc-200574
sc-200574A
100 µg
1 mg
$187.00
$843.00
14
(1)

An inhibitor of long-chain acyl-CoA synthetase, which could alter the lipid environment and indirectly affect the activity of dolichol kinase.

Nicotinamide

98-92-0sc-208096
sc-208096A
sc-208096B
sc-208096C
100 g
250 g
1 kg
5 kg
$44.00
$66.00
$204.00
$831.00
6
(1)

As an inhibitor of sirtuins, it can influence the post-translational modification of proteins and potentially impact the regulation of dolichol kinase activity.

Manumycin A

52665-74-4sc-200857
sc-200857A
1 mg
5 mg
$219.00
$634.00
5
(1)

An inhibitor of farnesyltransferase and could decrease the prenylation of proteins that may be involved in the regulation of dolichol kinase.